- Q2 2024 Cue Biopharma Inc Earnings Call Transcript6 days ago€0.585 (+9.35%)Earnings
- Q4 2023 Cue Biopharma Inc Earnings Call TranscriptApr 08, 2024€1.7 (+4.94%)Earnings
- Q3 2023 Cue Biopharma Inc Earnings Call and Business Update TranscriptNov 09, 2023€2.24 (-4.36%)Earnings
- Q2 2023 Cue Biopharma Inc Earnings Call TranscriptAug 09, 2023€3.2 (+3.16%)Earnings
- Cue Biopharma Inc To Host Business Update Call TranscriptJun 14, 2023
- Cue Biopharma Inc at Jefferies Healthcare Conference TranscriptJun 09, 2023
- Cue Biopharma Inc at JMP Securities Life Sciences Conference TranscriptMay 15, 2023
- Q4 2022 Cue Biopharma Inc Earnings Call TranscriptMar 21, 2023€2.86 (+2.14%)Earnings
- Q3 2022 Cue Biopharma Inc Earnings Call TranscriptNov 14, 2022€3Earnings
- Q2 2022 Cue Biopharma Inc Earnings And Business Update Call TranscriptAug 23, 2022
- Cue Biopharma Inc at JMP Securities Life Sciences Conference TranscriptJun 16, 2022
- Cue Biopharma Inc To Host Business Update And Ongoing CUE-101 Clinical Trials Call TranscriptJan 26, 2022
- Q2 2021 Cue Biopharma Inc Earnings Call TranscriptAug 17, 2021€8.45 (-8.65%)Earnings
- Q1 2021 Cue Biopharma Inc Earnings Call TranscriptMay 17, 2021€11.1 (+5.71%)Earnings
- Q4 2020 Cue Biopharma Inc Earnings Call TranscriptMar 16, 2021€12.5 (+5.93%)Earnings
- Cue Biopharma Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 04, 2021
- Cue Biopharma, Inc. - Special Call TranscriptNov 17, 2020
- Cue Biopharma Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 17, 2020
- Q2 2020 Cue Biopharma Inc Earnings Call TranscriptAug 31, 2020€14.7 (-1.34%)Earnings
- Q1 2020 Cue Biopharma Inc Earnings Call TranscriptMay 19, 2020€24Earnings
- Q4 2019 Cue Biopharma Inc Earnings Call TranscriptMar 17, 2020€11.6Earnings
- Cue Biopharma, Inc. - Special Call TranscriptNov 12, 2019
- Cue Biopharma Inc Investor Business Update TranscriptMay 21, 2019
- Cue Biopharma, Inc. - Special Call TranscriptMar 14, 2019
Cue Biopharma, Inc. - Special Call Transcript
Good afternoon, and welcome to Cue Biopharma's Quarterly Investor and Analyst Update Conference Call. (Operator Instructions) I will now turn the call over to John Woolford.
Good afternoon. This is John Woolford from Westwicke. Thank you for joining us on today's investor and analyst update call.
Joining me on the call today are Dan Passeri, Cue Biopharma's President and CEO; Dr. Anish Suri, Chief Scientific Officer; Dr. Ken Pienta, Acting Chief Medical Officer; and Kerri-Ann Millar, VP of Finance and Principal Accounting and Finance Officer. Also joining us on the call is Bethany Mancilla, our Chief Business Officer, who will be available for the Q&A section of the call. I want to note that a slide deck for today's call is available through the webcast in the Investors section of our website, www.cuebio.com.
Before we begin, I'd like to remind you that during today's call, the company will be making forward-looking statements.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)